Skip to content
2000
Volume 15, Issue 6
  • ISSN: 2210-3155
  • E-ISSN: 2210-3163

Abstract

Background

Forsythia-4 is an herbal formula commonly used in traditional Mongolian Medicinal clinics to treat peptic ulcers. However, the mechanism of its pharmacological components has not yet been fully characterized.

Aim

The study aimed to evaluate the biological basis for the clinical prevention and preventive treatment of uncontrolled liver function caused by metabolomics from Forsythia-4 to investigate the intervention mechanism in rats with liver injury caused by pyloric ligation (PL).

Methods

PL was performed to induce gastric and duodenal ulcers in rats, which were then treated with oral Forsythia-4 (Solongga-4) for 15 days. PL-induced Liver Damage. Therapeutic effects were characterized by pathological and histological evaluations, and inflammatory indicators were analyzed using an enzyme-linked immunosorbent assay. Microarray analyses were conducted to identify liver tissue gene expression profiles in PL rats with or without Forsythia-4 treatment and detected chemical composition by UPLC-Q/TOF-MS/MS.

Results

Forsythia-4's effects on rat serum revealed that the levels of ALT and AST in the model group were significantly higher ( < 0.01) than in the control group and that they were significantly lower ( < 0.05) in the medication administration group than in the model group. The contents of BILD2 and SBIL3 in the model group were considerably higher ( < 0.01) compared with the control group and significantly lower ( < 0.05) in the medication administration group compared with the model group. These effects of Forsythia-4 in serum with pyloric ligation liver injury. In rats with liver damage brought on by pyloric ligation, Forsythia-4's serum metabolic profile study revealed 25 metabolic alterations from the model group and 39 metabolites from the drug administration group. IGFBP1, which was upregulated in the model group compared to the control group and down-regulated in the administration group compared to the model group, was the regulator of the differential metabolite's pathway for arachidonic acid metabolism.

Conclusion

Pyloric ligation can alter the regulation of the IGFBP1 factor in the pathway that produces adipose tissue, and after Forsythia-4 intervention, the regulation of the IGFBP1 factor in the route that produces adipose tissue returns to normal.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/npj/10.2174/0122103155315546240708114752
2024-07-15
2025-11-05

  • From This Site

    /content/journals/npj/10.2174/0122103155315546240708114752
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Plants of the World OnlineFacilitated by the Royal Botanic Gardens, Kew.2024Available from: http://www.plantsoftheworldonline.org/ Retrieved 25 May 2024.
  2. QuS. BaoJ. AoW. BaiL. BorjigidaiA. Mongolian medicine: History, development and existing problems.Chin. Herb. Med.202214334535510.1016/j.chmed.2022.06.004 36117997
     [Google Scholar]
  3. QuD. History, current situation, and future development of Mongolian medicine.J. Tradit. Chin. Med. Sci.20218S17S21
     [Google Scholar]
  4. KletterC. GlaslS. ThalhammerT. NarantuyaS. Traditional mongolian medicine – A potential for drug discovery.Sci. Pharm.2008761496310.3797/scipharm.0802‑04
     [Google Scholar]
  5. ZangY.C. JangS.Q. KangS.L. XuC. BaiY.L. Pharmaceutical Standards of the Ministry of Health of the People’s Republic of China (Mongolian Medicine).Pharmacopoeia Commission of the Ministry of Health of the People's Republic of China1998
     [Google Scholar]
  6. WangH. WangX.L. Bai, l.; Wang, T.Y. Establishment of a rat model of pyloric ligation in Mongolian medicine.J Med Pharm Chin Minor2013124649
     [Google Scholar]
  7. WangH. TongS. XiaoM. WangB.G.L. WangT.Y. Protective effect of Mongolian medicine “Sulongga-4 -flavor Decoction Powder ” on liver injury induced by pyloric ligation.Chin J Exp Tradit Med201320250254
     [Google Scholar]
  8. WangH. BaG.N. Protective effect of Mongolian medicine “Sulongga-4 Decoction Powder” on liver injury induced by pyloric ligation.J Inner Mongolia Univ National.20151812
     [Google Scholar]
  9. HanB.G.N. WangH. BuR.E. HongG.E. WangT.Y. Protective effect of Mongolian medicine “Honglin-5” capsule on liver injury model of pyloric ligation.Liaoning J Tradit Chin Med.2016510861088
     [Google Scholar]
  10. WangH. TongS. HanH.M. KhalzaabaastT. BaoB.G.N. Liver protein spectrum analysis in rat liver injury model.Int. J. Clin. Exp. Med.201811763847518
     [Google Scholar]
  11. WangH. Effect of digda-4 on the expression of PXR and CAR in liver injury induced by pyloric ligation.Chin J Tradit Chin Med Pharmacol.20171255785582
     [Google Scholar]
  12. WangH. BaG.N. Protective effect and mechanism of Mongolian medicine Diqueda-4 decoction and Sulongga-4 decoction on pyloric ligation induced liver injury in rats. Tongliao.Inner Mongolia University for Nationalities2016
     [Google Scholar]
  13. WangH. HongM. Protective effect and mechanism of Digeda-4 decoction on liver injury induced by pyloric ligation.Chin Arch Tradit Chin Med.2017012932
     [Google Scholar]
  14. WangH. TongS. HongM. XuY.H. BaT.D.L.G. HanZ.Q. Expression of MRP3 and MRP4 in hepatic cell membrane after pyloric ligation in rats.World Chin. J. Digestology2016121853185910.11569/wcjd.v24.i12.1853
     [Google Scholar]
  15. WangH. The effect of Mongolian drug digda-4 decoction in the acute liver injury induced by “pylorus ligation” in rats.Diagnosis (Berl.)20161525
     [Google Scholar]
  16. TongS. WangH. A, L.S.; Bai, T. N.; Gong, J. H.; Jin, W. J.; Fu, M. H. Protective effect and mechanisms of action of Mongolian medicine Sulongga-4 on pyloric ligation-induced gastroduodenal ulcer in rats.World J. Gastroenterol.20211617701784
     [Google Scholar]
  17. NiuJ.Y. HouL.H. KouL.H. WangY. QuY.F. Current situation and reflection on the essential research of TCM syndrome by using omics technology.Zhonghua Zhongyiyao Zazhi20181042714274
     [Google Scholar]
  18. ZhaoC.Q. LiuC. LiuP. ZhangH. Research progress of TCM syndrome classification based on metabolomics method.World Chinese Medicine20174956960
     [Google Scholar]
  19. DuanS.J. YaoS.k. WeiR.j. ChenJ.L. ChengY. Systems Biology -- A bridge between Chinese and Western medicine.Chin J Integr Tradit West Med20191214181421
     [Google Scholar]
  20. ClàriaJ. ArroyoV. Prostaglandins and other cyclooxygenase-dependent arachidonic acid metabolites and the kidney in liver disease.Prostaglandins Other Lipid Mediat.2003721-2193310.1016/S1098‑8823(03)00075‑3 14626494
     [Google Scholar]
  21. JinR. KoopD.R. RaucyJ.L. LaskerJ.M. Role of human CYP4F2 in hepatic catabolism of the proinflammatory agent leukotriene B4.Arch. Biochem. Biophys.19983591899810.1006/abbi.1998.0880 9799565
     [Google Scholar]
  22. YangY. ZhaoL. YangZ.L. KeT.Y. Research progress of insulin-like growth factor 1 in diabetes mellitus and its complications.Letters in Biotechnology20205600606
     [Google Scholar]
  23. KwonO.C. LeeE.J. OhJ.S. HongS. LeeC.K. YooB. ParkM.C. KimY.G. Plasma immunoglobulin binding protein 1 as a predictor of development of lupus nephritis.Lupus202029654755310.1177/0961203320912336 32183589
     [Google Scholar]
  24. ChenD. FanY. WanF. LncRNA IGBP1-AS1/miR-24-1/ZIC3 loop regulates the proliferation and invasion ability in breast cancer.Cancer Cell Int.202020115310.1186/s12935‑020‑01214‑x 32390766
     [Google Scholar]
  25. GianuzziX. Palma-ArdilesG. Hernandez-FernandezW. PasupuletiV. HernandezA.V. Perez-LopezF.R. Insulin growth factor (IGF) 1, IGF-binding proteins and ovarian cancer risk: A systematic review and meta-analysis.Maturitas201694222910.1016/j.maturitas.2016.08.012 27823741
     [Google Scholar]
  26. YoungC.H. SnowB. DeVoreS.B. MohandassA. NemmaraV.V. ThompsonP.R. ThyagarajanB. NavratilA.M. CherringtonB.D. Progesterone stimulates histone citrullination to increase IGFBP1 expression in uterine cells.Reproduction2021162211712710.1530/REP‑21‑0132 34034233
     [Google Scholar]
  27. WangC. L The effect of H3R117 single ADP ribosylation on lipid metabolism in colorectal cancer by regulating IGFBP1 methylation.Doctoral dissertation, Chongqing: Chongqing Medical University2021
     [Google Scholar]
  28. BallaM.M.S. PatwardhanS. MelwaniP.K. PurwarP. KumarA. PrameshC.S. LaskarS. PandeyB.N. Prognosis of metastasis based on age and serum analytes after follow-up of non-metastatic lung cancer patients.Transl. Oncol.202114110093310.1016/j.tranon.2020.100933 33188981
     [Google Scholar]
  29. GuoC.R. Application of high-throughput sequencing and bioinformatics analysis in neurofibromatosis type 1Shanghai jiao tong university: Shanghai2020
     [Google Scholar]
  30. QiG.Q.T. Concise Medicine.HohhotInner Mongolia People's Medical Publishing House1983
     [Google Scholar]
/content/journals/npj/10.2174/0122103155315546240708114752
Loading
Metabolomic Study on the Intervention Mechanism of the Mongolian Medicine Forsythia-4 in Rats with Liver Damage Induced by Pyloric Ligation
Natural Products Journal, The 15, E150724231967 (2025); https://doi.org/10.2174/0122103155315546240708114752
/content/journals/npj/10.2174/0122103155315546240708114752
/content/journals/npj/10.2174/0122103155315546240708114752
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): Essence and dross decomposition theory; intervention mechanism of forsythia-4; liver injury; metabolites; metabolomics; pyloric ligation

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test